DOW JONES23,124.40+444.41 1.96%
S&P 5002,707.41+43.73 1.64%
NASDAQ8,043.10+129.86 1.64%

UPDATE: Tonix Pharma Says Co. Is Currently Enrolling Phase 3 Study Of TNX-102 In Fibromyalgia Syndrome, Sees Interim Results In Q3

Benzinga · 02/05/2020 22:17